Outcomes of surgical treatment for patients with distal rectal cancer: A retrospective review from a single university hospital

Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Citação
REVISTA DE GASTROENTEROLOGIA DE MEXICO, v.85, n.2, p.180-189, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
introduction and aim: Surgery for distal rectal cancer (DRC) can be performed with or without sphincter preservation. The aim of the present study was to analyze the outcomes of two surgical techniques in the treatment of DRC patients: low anterior resection (LAR) and abdominoperineal resection (APR). Methods: Patients with advanced DRC that underwent surgical treatment between 2002 and 2012 were evaluated. We compared the outcomes of the type of surgery (APR vs LAR) and analyzed the associations of survival and recurrence with the following factors: age, sex, tumor location, lymph nodes obtained, lymph node involvement, and rectal wall involvement. Patients with distant metastases were excluded. Results: A total of 148 patients were included, 78 of whom were females (52.7%). The mean patient age was 61.2 years. Neoadjuvant chemoradiation therapy was performed in 86.5% of the patients. APR was performed on 86 (58.1%) patients, and LAR on 62 (41.9%) patients. No differences were observed between the two groups regarding clinical and oncologic characteristics. Eighty-seven (62%) patients had pT3-4 disease, and 41 patients (27.7%) had lymph node involvement. In the multivariate analysis, only poorly differentiated tumors (P=.026) and APR (P=.009) correlated with higher recurrence rates. Mean follow-up time was 32 (16-59.9) months. Overall 5 -year survival was 58.1%. The 5 -year survival rate was worse in patients that underwent APR (46.5%) than in the patients that underwent LAR (74.2%) (P=.009). Conclusions: Patients with locally advanced DRC that underwent APR presented with a lower survival rate and a higher local recurrence rate than patients that underwent LAR. In addition, advanced T/stage, lymph node involvement, and poor tumor differentiation were associated with recurrence and a lower survival rate, regardless of the procedure. 2020 Asociacion Mexicana de Gastroenterologia.
Palavras-chave
Referências
  1. Bujko K, 2012, INDIA J SURG ONCOL, V3, P139, DOI 10.1007/s13193-012-0158-y
  2. Chuwa EWL, 2006, DIS COLON RECTUM, V49, P41, DOI 10.1007/s10350-005-0227-1
  3. Doll D, 2009, WORLD J SURG, V33, P340, DOI 10.1007/s00268-008-9838-8
  4. Edge S, 2010, AJCC CANC STAGING MA, P648
  5. Guillem JG, 2005, ANN SURG, V241, P829, DOI 10.1097/01.sla.0000161980.46459.96
  6. Ha YH, 2010, ANN SURG, V252, P336, DOI 10.1097/SLA.0b013e3181e61e33
  7. Hanly AM, 2014, ANN SURG, V259, P723, DOI 10.1097/SLA.0b013e31828f6c91
  8. Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894
  9. HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019
  10. Herrle F, 2016, DIS COLON RECTUM, V59, P281, DOI 10.1097/DCR.0000000000000545
  11. Holm T, 2007, BRIT J SURG, V94, P232, DOI 10.1002/bjs.5489
  12. Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580
  13. Kim NK, 2006, ANN SURG, V244, P1024, DOI 10.1097/01.sla.0000225360.99257.73
  14. Koh DM, 2005, EUR RADIOL, V15, P1650, DOI 10.1007/s00330-005-2751-8
  15. Law WL, 2004, BRIT J SURG, V91, P1493, DOI 10.1002/bjs.4723
  16. LLOYDDAVIES OV, 1947, P ROY SOC MED, V40, P875, DOI 10.1177/003591574704001408
  17. Martin ST, 2012, BRIT J SURG, V99, P603, DOI 10.1002/bjs.8677
  18. MCANENA OJ, 1990, SURG GYNECOL OBSTET, V170, P517
  19. Miles WE, 1908, LANCET, V2, P1812, DOI 10.1016/s0140-6736(00)99076-7
  20. POLLETT WG, 1983, ANN SURG, V198, P159, DOI 10.1097/00000658-198308000-00008
  21. RUBBINI M, 1990, DIS COLON RECTUM, V33, P117, DOI 10.1007/BF02055539
  22. Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694
  23. Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
  24. Silva Mario, 2016, ESTIMATIVA 2016 INCI
  25. Wibe A, 2004, DIS COLON RECTUM, V47, P48, DOI 10.1007/s10350-003-0012-y
  26. Zhao GP, 2005, WORLD J GASTROENTERO, V11, P319, DOI 10.3748/wjg.v11.i3.319
  27. Zhao RS, 2014, DIS COLON RECTUM, V57, P388, DOI 10.1097/DCR.0000000000000022